MedTrace Logo

An Accessible Low-cost Plant Treatment for Cutaneous Ulcers

NCT04453124 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 150

Last updated 2020-09-03

No results posted yet for this study

Summary

In a search for accessible treatment options, plant medicines used by different communities in Papua New Guinea have been tested to identify the sap of the tree, Ficus septica, as a promising antibacterial agent in vitro.

This is an open label clinical trial using an interventional approach, to compare the effect of the antiseptic plant sap and standard topical antiseptic, on the rate of wound development prevention and bacterial growth. If shown to be effective, this readily available plant medicine can provide a zero-cost treatment option in remote areas of PNG.

Conditions

  • Yaws; Cutaneous
  • Cutaneous Ulcer
  • Yaws

Interventions

BIOLOGICAL

Topical antiseptic treatment

Prevent the development of bacterial cutaneous ulcers by applying antiseptic sap from Ficus septica tree on small wounds.

Sponsors & Collaborators

  • The University of Papua New Guinea

    collaborator UNKNOWN

  • The Royal Botanic Gardens, Kew

    collaborator UNKNOWN

  • Oriol Mitja

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
5 Years
Max Age
15 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-11-01
Primary Completion
2019-11-22
Completion
2019-11-25

Countries

  • Papua New Guinea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04453124 on ClinicalTrials.gov